(S,S)-(+)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine, 95.0%, 5g

4-Methylbenzenesulfonyl cyanide, 95.0%, 200mg

(S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-(3,5-DIFLUOROPHENYL)BUTANOIC ACID, 95%, 100mg

Cestello di sterilizzazione ROTILABO®, 160 mm 1 pezzo

Tris(2,2'-bipyridyl)ruthenium(II) Chloride Hexahydrate>98.0%(T)1g

Dibenzofuran-2-carboxaldehyde, 95.0%, 250mg

Carte lisce, MN 260, 60 x 58 cm, 0,20 mm, 100 Pezzo(i)

Perossido di idrogeno, 30%, per sintesi, stabilizzato, 500 ml, confezione in plastica.

(4-Bromo-3,5-dichlorophenyl)methanol, 95+%, 10g

(3-Hydroxymethyl-piperidin-1-yl)-acetic acid, 100mg

1-(1H-Benzoimidazol-5-yl)-ethanone, 95.0%, 100mg

3-(2-Pyridin-2-yl-ethyl)-phenylamine, 95.0%, 1g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-iodobenzyl)pyrrolidine-2-carboxylic acid, 97%, 250mg